These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4035232)

  • 21. [Therapy of sudden deafness--naftidrofuryl (Dusodril) and pentoxifylline (Trental) compared].
    Laskawi R; Schrader B; Schröder M; Poser R; von der Brelie R
    Laryngol Rhinol Otol (Stuttg); 1987 May; 66(5):242-5. PubMed ID: 3302568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pentoxifylline in changes of the statoacoustic apparatus during vascular diseases. Its action on erythrocyte flexibility].
    Pallestrini E; Garaventa G; Cagetti P; Benedetti G; Valle MT; Accomando E; Castiglia G
    Clin Ter; 1986 Aug; 118(4):239-46. PubMed ID: 3489580
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
    Pilla G; Ciaponi A; Migliavacca A; Bonora C
    Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of pentoxifylline in a pig random skin flap model.
    Knox RD; Pratt MF; Adkins WY; Flick JT
    Laryngoscope; 1989 Jun; 99(6 Pt 1):582-5. PubMed ID: 2725152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker?
    Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
    J Nephrol; 2007; 20(4):410-6. PubMed ID: 17879206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO; Jeffers BW; Gifford N; Schrier RW
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants.
    Herskovits E; Famulari A; Tamaroff L; Gonzalez AM; Vázquez A; Dominguez R; Fraiman H; Vila J
    Eur Neurol; 1985; 24(1):73-81. PubMed ID: 3881263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
    Vaya A; Martínez M; Carbonell P; Aznar J
    Angiologia; 1987; 39(6):262-8. PubMed ID: 3425972
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of fructose-1,6-diphosphate on the red cell deformability in diabetic patients.
    Marsilii A; Petruzzi E; Di Noto C; Marini P
    Agressologie; 1984 Sep; 25(8):919-21. PubMed ID: 6507765
    [No Abstract]   [Full Text] [Related]  

  • 30. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentoxifylline, diltiazem, and A23187: effects on deformability and volume of human red blood cells.
    Dodson RA; Hinds TR; Vincenzi FF
    Proc West Pharmacol Soc; 1988; 31():205-7. PubMed ID: 3145500
    [No Abstract]   [Full Text] [Related]  

  • 32. Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.
    Guerrero-Romero F; Rodríguez-Morán M; Paniagua-Sierra JR; García-Bulnes G; Salas-Ramírez M; Amato D
    Clin Nephrol; 1995 Feb; 43(2):116-21. PubMed ID: 7736673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.
    Navarro JF; Mora C; Muros M; García J
    J Am Soc Nephrol; 2005 Jul; 16(7):2119-26. PubMed ID: 15917336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of pentoxifylline on filterability of normal red blood cells and their adhesiveness to cultured endothelial cells.
    Sowemimo-Coker SO; Turner P
    Eur J Clin Pharmacol; 1985; 29(1):55-9. PubMed ID: 2996906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pentoxifylline and intermittent claudication.
    Spittel JA
    Ann Intern Med; 1985 Jan; 102(1):126-7. PubMed ID: 3966730
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
    Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
    G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy].
    Dakhli S; Lamine S; Lamine F; Trabelsi N; Aouididi F; Zouaoui C; Mami FB; Achour A
    Tunis Med; 2007 Nov; 85(11):945-50. PubMed ID: 19166146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study on relationship between erythrocyte filtration and other risk factors in diabetic angiopathy.
    Pozza G; Cordaro C; Carandente O; Margonato A
    Ric Clin Lab; 1981; 11 Suppl 1():317-26. PubMed ID: 7188119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.